Bristol-Myers Squibb Co. (BMY)

• Annual Data
• Quarterly Data

• Annual Data
• Quarterly Data

Bristol-Myers Squibb Co., short-term (operating) activity ratios

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).

Ratio	Description	The company
Inventory turnover	An activity ratio calculated as cost of goods sold divided by inventory.	Bristol-Myers Squibb Co.'s inventory turnover improved from 2015 to 2016 and from 2016 to 2017.
Receivables turnover	An activity ratio equal to revenue divided by receivables.	Bristol-Myers Squibb Co.'s receivables turnover deteriorated from 2015 to 2016 and from 2016 to 2017.
Payables turnover	An activity ratio calculated as cost of goods sold divided by payables.	Bristol-Myers Squibb Co.'s payables turnover increased from 2015 to 2016 but then slightly declined from 2016 to 2017 not reaching 2015 level.
Working capital turnover	An activity ratio calculated as revenue divided by working capital.	Bristol-Myers Squibb Co.'s working capital turnover deteriorated from 2015 to 2016 and from 2016 to 2017.

Ratio	Description	The company
Average inventory processing period	An activity ratio equal to the number of days in the period divided by inventory turnover over the period.	Bristol-Myers Squibb Co.'s average inventory processing period improved from 2015 to 2016 and from 2016 to 2017.
Average receivable collection period	An activity ratio equal to the number of days in the period divided by receivables turnover.	Bristol-Myers Squibb Co.'s average receivable collection period deteriorated from 2015 to 2016 and from 2016 to 2017.
Operating cycle	Equal to average inventory processing period plus average receivables collection period.	Bristol-Myers Squibb Co.'s operating cycle improved from 2015 to 2016 and from 2016 to 2017.
Average payables payment period	An estimate of the average number of days it takes a company to pay its suppliers; equal to the number of days in the period divided by payables turnover ratio for the period.	Bristol-Myers Squibb Co.'s average payables payment period declined from 2015 to 2016 but then increased from 2016 to 2017 not reaching 2015 level.
Cash conversion cycle	A financial metric that measures the length of time required for a company to convert cash invested in its operations to cash received as a result of its operations; equal to average inventory processing period plus average receivables collection period minus average payables payment period.	Bristol-Myers Squibb Co.'s cash conversion cycle deteriorated from 2015 to 2016 but then improved from 2016 to 2017 exceeding 2015 level.

• Annual Data
• Quarterly Data

Bristol-Myers Squibb Co., inventory turnover calculation, comparison to benchmarks

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).

2017 Calculations

Ratio	Description	The company
Inventory turnover	An activity ratio calculated as cost of goods sold divided by inventory.	Bristol-Myers Squibb Co.'s inventory turnover improved from 2015 to 2016 and from 2016 to 2017.

Bristol-Myers Squibb Co., receivables turnover calculation, comparison to benchmarks

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).

2017 Calculations

Ratio	Description	The company
Receivables turnover	An activity ratio equal to revenue divided by receivables.	Bristol-Myers Squibb Co.'s receivables turnover deteriorated from 2015 to 2016 and from 2016 to 2017.

• Annual Data
• Quarterly Data

Bristol-Myers Squibb Co., payables turnover calculation, comparison to benchmarks

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).

2017 Calculations

Ratio	Description	The company
Payables turnover	An activity ratio calculated as cost of goods sold divided by payables.	Bristol-Myers Squibb Co.'s payables turnover increased from 2015 to 2016 but then slightly declined from 2016 to 2017 not reaching 2015 level.

• Annual Data
• Quarterly Data

Bristol-Myers Squibb Co., working capital turnover calculation, comparison to benchmarks

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).

2017 Calculations

Ratio	Description	The company
Working capital turnover	An activity ratio calculated as revenue divided by working capital.	Bristol-Myers Squibb Co.'s working capital turnover deteriorated from 2015 to 2016 and from 2016 to 2017.

• Annual Data
• Quarterly Data

Bristol-Myers Squibb Co., average inventory processing period calculation, comparison to benchmarks

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).

2017 Calculations

Ratio	Description	The company
Average inventory processing period	An activity ratio equal to the number of days in the period divided by inventory turnover over the period.	Bristol-Myers Squibb Co.'s average inventory processing period improved from 2015 to 2016 and from 2016 to 2017.

Bristol-Myers Squibb Co., average receivable collection period calculation, comparison to benchmarks

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).

2017 Calculations

Ratio	Description	The company
Average receivable collection period	An activity ratio equal to the number of days in the period divided by receivables turnover.	Bristol-Myers Squibb Co.'s average receivable collection period deteriorated from 2015 to 2016 and from 2016 to 2017.

Bristol-Myers Squibb Co., operating cycle calculation, comparison to benchmarks

No. of days

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).

2017 Calculations

Ratio	Description	The company
Operating cycle	Equal to average inventory processing period plus average receivables collection period.	Bristol-Myers Squibb Co.'s operating cycle improved from 2015 to 2016 and from 2016 to 2017.

• Annual Data
• Quarterly Data

Bristol-Myers Squibb Co., average payables payment period calculation, comparison to benchmarks

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).

2017 Calculations

Ratio	Description	The company
Average payables payment period	An estimate of the average number of days it takes a company to pay its suppliers; equal to the number of days in the period divided by payables turnover ratio for the period.	Bristol-Myers Squibb Co.'s average payables payment period declined from 2015 to 2016 but then increased from 2016 to 2017 not reaching 2015 level.

Bristol-Myers Squibb Co., cash conversion cycle calculation, comparison to benchmarks

No. of days

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).

2017 Calculations

Ratio	Description	The company
Cash conversion cycle	A financial metric that measures the length of time required for a company to convert cash invested in its operations to cash received as a result of its operations; equal to average inventory processing period plus average receivables collection period minus average payables payment period.	Bristol-Myers Squibb Co.'s cash conversion cycle deteriorated from 2015 to 2016 but then improved from 2016 to 2017 exceeding 2015 level.